Related Experiment Video
Updated: May 31, 2026
10:04
Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
Ethical issues in tuberculosis diagnosis and treatment
1Centre for Human Bioethics, School of Philosophical, Historical and International Studies, Monash University, Clayton, Victoria, Australia.
Summary
Drug-resistant tuberculosis (TB) demands ethical discussions on diagnosis and treatment. Addressing patient adherence, physician practices, and industry incentives is crucial for global TB control and preventing further drug resistance.
Area of Science:
- Public Health
- Bioethics
- Infectious Diseases
Background:
- Drug-resistant tuberculosis (TB) presents significant ethical challenges in diagnosis and treatment.
- Factors contributing to drug resistance include patient non-adherence and suboptimal physician prescribing.
- Limited industry motivation for developing new TB drugs and diagnostics exacerbates the global TB burden.
Purpose of the Study:
- To explore the primary ethical issues in TB diagnosis and treatment.
- To examine human rights considerations, including universal access and standards of care.
- To address challenges related to treatment cessation, privacy, stigmatization, and diagnostic capacity.
Main Methods:
- Ethical analysis of TB diagnosis and treatment practices.
- Review of human rights requirements in healthcare access and standards.
- Examination of privacy concerns within directly observed therapy.
- Assessment of diagnostic limitations due to laboratory capacity.
Main Results:
- Improving individual patient care is ethically imperative to prevent infection spread and worsening drug resistance.
- Protecting public health may necessitate increased regulation of the private sector.
- There is a need for greater incentives for industry to develop novel TB control tools.
Conclusions:
- Ethical considerations are paramount in combating drug-resistant TB.
- Balancing individual rights with public health goals is essential.
- Collaborative efforts, including industry engagement, are vital for effective TB control.
Related Concept Videos
01:28Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
01:26Pulmonary Tuberculosis IV
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
01:29Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
01:31Pulmonary Tuberculosis III
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
01:56Ethics in Research
Today, scientists agree that good research is ethical in nature and is guided by a basic respect for human dignity and safety. However, this has not always been the case. Modern researchers must demonstrate that the research they perform is ethically sound.
01:23Tuberculosis
Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...